Jaakkola U, Koulu M, Karvonen M K, Seppälä H, Pesonen U, Vahlberg T, Kallio J
Department of Pharmacology, Drug Development and Therapeutics, University of Turku, Turku, Finland.
Exp Clin Endocrinol Diabetes. 2007 May;115(5):281-6. doi: 10.1055/s-2007-977696.
Neuropeptide Y (NPY) is a sympathetic neurotransmitter that plays a role in e.g. circulation, hormone release and angiogenesis. Earlier studies have shown that the Leucine 7 to Proline 7 (Leu7Pro) polymorphism of preproNPY is associated with increased risk for vascular complications in type 2 diabetes. The mechanism for this maybe altered transmitter and hormone levels or altered cardiovascular functions, which have been observed in healthy subjects having the Leu7Pro polymorphism. The current study was undertaken to explore if the Leu7Pro polymorphism has an impact on these functions in subjects with type 2 diabetes. Diurnal measurements were performed for Finnish Caucasian type 2 diabetes patients of two preproNPY genotypes (matched by sex, age, BMI, duration of diabetes and HbA1c) in resting position to prevent sympathetic stimulation. Standard meals were offered during the 24-hour study period. Nine subjects with the Leu7Pro polymorphism and ten subjects without this polymorphism were studied. Plasma concentrations of NPY, glucose, insulin, cortisol, prolactin and leptin were measured by taking blood samples at 20 time points (from 8 a.m. to 8 a.m.). Heart rate and blood pressure were measured at the same time points. The results show that NPY concentrations were similar in both preproNPY genotypes. Glucose, insulin, cortisol and leptin concentrations as well as heart rate and blood pressure were also similar. However, a significant difference between genotypes was found in the association of NPY concentrations with cortisol concentrations (p for difference=0.002). Also a statistically significant negative association of plasma NPY levels with plasma glucose levels was found in both genotypes. Since no impact of preproNPY genotype on mean NPY or hormone levels were detected in subjects with type 2 diabetes, the mechanisms for the increased risk for diabetic complications in the subjects with the Leu7Pro polymorphism need to be further explored.
神经肽Y(NPY)是一种交感神经递质,在例如循环、激素释放和血管生成等方面发挥作用。早期研究表明,前神经肽Y的亮氨酸7突变为脯氨酸7(Leu7Pro)多态性与2型糖尿病血管并发症风险增加有关。其机制可能是递质和激素水平改变或心血管功能改变,这在具有Leu7Pro多态性的健康受试者中已被观察到。本研究旨在探讨Leu7Pro多态性对2型糖尿病患者这些功能是否有影响。对两种前神经肽Y基因型(按性别、年龄、体重指数、糖尿病病程和糖化血红蛋白匹配)的芬兰白种人2型糖尿病患者在静息状态下进行昼夜测量,以防止交感神经刺激。在24小时研究期间提供标准餐食。研究了9名具有Leu7Pro多态性的受试者和10名无此多态性的受试者。通过在20个时间点(从上午8点到上午8点)采集血样来测量血浆中NPY、葡萄糖、胰岛素、皮质醇、催乳素和瘦素的浓度。在相同时间点测量心率和血压。结果显示,两种前神经肽Y基因型的NPY浓度相似。葡萄糖、胰岛素、皮质醇和瘦素浓度以及心率和血压也相似。然而,在NPY浓度与皮质醇浓度的关联中发现基因型之间存在显著差异(差异p = 0.002)。在两种基因型中还发现血浆NPY水平与血浆葡萄糖水平存在统计学上显著的负相关。由于在2型糖尿病患者中未检测到前神经肽Y基因型对平均NPY或激素水平有影响,因此需要进一步探索具有Leu7Pro多态性的患者糖尿病并发症风险增加的机制。